 Cardiomyopathies
"Cardiomyopathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Descriptor ID |
D009202
|
| MeSH Number(s) |
C14.280.238
|
| Concept/Terms |
Cardiomyopathies- Cardiomyopathies
- Cardiomyopathy
- Myocardial Diseases
- Disease, Myocardial
- Diseases, Myocardial
- Myocardial Disease
- Myocardiopathies
- Myocardiopathy
Cardiomyopathies, Secondary- Cardiomyopathies, Secondary
- Cardiomyopathy, Secondary
- Secondary Cardiomyopathies
- Secondary Cardiomyopathy
- Secondary Myocardial Diseases
- Disease, Secondary Myocardial
- Diseases, Secondary Myocardial
- Myocardial Disease, Secondary
- Secondary Myocardial Disease
- Myocardial Diseases, Secondary
Cardiomyopathies, Primary- Cardiomyopathies, Primary
- Cardiomyopathy, Primary
- Primary Cardiomyopathies
- Primary Cardiomyopathy
- Primary Myocardial Diseases
- Myocardial Diseases, Primary
- Disease, Primary Myocardial
- Diseases, Primary Myocardial
- Myocardial Disease, Primary
- Primary Myocardial Disease
|
Below are MeSH descriptors whose meaning is more general than "Cardiomyopathies".
Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathies".
This graph shows the total number of publications written about "Cardiomyopathies" by people in UAMS Profiles by year, and whether "Cardiomyopathies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2020 | 3 | 0 | 3 | | 2019 | 4 | 0 | 4 | | 2018 | 1 | 0 | 1 | | 2017 | 2 | 2 | 4 | | 2016 | 4 | 0 | 4 | | 2015 | 3 | 2 | 5 | | 2014 | 2 | 0 | 2 | | 2013 | 1 | 0 | 1 | | 2012 | 2 | 1 | 3 | | 2011 | 3 | 1 | 4 | | 2010 | 1 | 1 | 2 | | 2009 | 1 | 2 | 3 | | 2008 | 1 | 0 | 1 | | 2007 | 0 | 1 | 1 | | 2006 | 2 | 0 | 2 | | 2005 | 0 | 2 | 2 | | 2004 | 0 | 1 | 1 | | 2003 | 2 | 2 | 4 | | 2002 | 1 | 1 | 2 | | 1999 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 1996 | 0 | 1 | 1 | | 1994 | 0 | 1 | 1 | | 1993 | 1 | 0 | 1 | | 1991 | 1 | 0 | 1 | | 1990 | 1 | 0 | 1 | | 1989 | 2 | 0 | 2 | | 1986 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Cardiomyopathies" by people in Profiles over the past ten years.
-
Siddiqui S, Alsaied T, Henson SE, Gandhi J, Patel P, Khoury P, Villa C, Ryan TD, Wittekind SG, Lang SM, Taylor MD. Left Ventricular Magnetic Resonance Imaging Strain Predicts the Onset of Duchenne Muscular Dystrophy-Associated Cardiomyopathy. Circ Cardiovasc Imaging. 2020 11; 13(11):e011526.
-
Park J, Yang K, Lee SH, Lee JH, Min JJ, Kwon JH, Oh AR, Yeo J, Kim J, Choi JH, Lee SC, Gwon HC, Kim K, Ahn J, Lee SM. Comparison of acute and chronic myocardial injury in noncardiac surgical patients. PLoS One. 2020; 15(7):e0234776.
-
Wittlieb-Weber CA, Knecht KR, Villa CR, Cunningham C, Conway J, Bock MJ, Gambetta KE, Lal AK, Schumacher KR, Law SP, Deshpande SR, West SC, Friedland-Little JM, Lytrivi ID, McCulloch MA, Butts RJ, Weber DR, Johnson JN. Risk Factors for Cardiac and Non-cardiac Causes of Death in Males with Duchenne Muscular Dystrophy. Pediatr Cardiol. 2020 Apr; 41(4):764-771.
-
Dasgupta S, Madani R, Figueroa J, Cox D, Ferguson E, Border W, Sachdeva R, Fischbach P, Whitehill R. Myocardial deformation as a predictor of right ventricular pacing-induced cardiomyopathy in the pediatric population. J Cardiovasc Electrophysiol. 2020 01; 31(1):337-344.
-
Lang SM, Alsaied T, Moore RA, Rattan M, Ryan TD, Taylor MD. Conservative gadolinium administration to patients with Duchenne muscular dystrophy: decreasing exposure, cost, and time, without change in medical management. Int J Cardiovasc Imaging. 2019 Dec; 35(12):2213-2219.
-
Bradford TT, Daily JA, Lang SM, Gossett JM, Tang X, Collins RT. Comparison of inhospital outcomes of pediatric heart transplantation between single ventricle congenital heart disease and cardiomyopathy. Pediatr Transplant. 2019 09; 23(6):e13495.
-
Abdul Ghaffar Y, Maskoun W, Mustafa NG, Feigenbaum H, Sawada SG. Low dose wall motion score predicts the short and long-term benefit of surgical revascularization in patients with ischemic left ventricular dysfunction. Int J Cardiovasc Imaging. 2019 Sep; 35(9):1651-1659.
-
Maskoun W, Saad M, Abualsuod A, Nairooz R, Miller JM. Outcome of catheter ablation for ventricular tachycardia in patients with ischemic cardiomyopathy: A systematic review and meta-analysis of randomized clinical trials. Int J Cardiol. 2018 Sep 15; 267:107-113.
-
Armstrong BA, Betzold RD, May AK. Sepsis and Septic Shock Strategies. Surg Clin North Am. 2017 Dec; 97(6):1339-1379.
-
Wen JJ, Porter C, Garg NJ. Inhibition of NFE2L2-Antioxidant Response Element Pathway by Mitochondrial Reactive Oxygen Species Contributes to Development of Cardiomyopathy and Left Ventricular Dysfunction in Chagas Disease. Antioxid Redox Signal. 2017 Sep 20; 27(9):550-566.
-
Schloemer NJ, Brickler M, Hoffmann R, Pan A, Simpson P, McFadden V, Block J, Tower RL, Burke MJ. Administration of Dexrazoxane Improves Cardiac Indices in Children and Young Adults With Acute Myeloid Leukemia (AML) While Maintaining Survival Outcomes. J Pediatr Hematol Oncol. 2017 07; 39(5):e254-e258.
-
Barakat AF, Saad M, Elgendy IY. Letter by Barakat et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis". Circulation. 2017 06 20; 135(25):e1196-e1197.
-
Bhatti S, Vallurupalli S, Ambach S, Magier A, Watts E, Truong V, Hakeem A, Mazur W. Myocardial strain pattern in patients with cardiac amyloidosis secondary to multiple myeloma: a cardiac MRI feature tracking study. Int J Cardiovasc Imaging. 2018 Jan; 34(1):27-33.
-
Raina S, Lensing SY, Nairooz RS, Pothineni NV, Hakeem A, Bhatti S, Pandey T. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis. JACC Cardiovasc Imaging. 2016 11; 9(11):1267-1277.
-
Abraham BP, Gilliam E, Kim DW, Wolf MJ, Vincent RN, Petit CJ. Early catheterization after initiation of extracorporeal membrane oxygenation support in children is associated with improved survival. Catheter Cardiovasc Interv. 2016 Oct; 88(4):592-599.
-
Niss O, Quinn CT, Lane A, Daily J, Khoury PR, Bakeer N, Kimball TR, Towbin JA, Malik P, Taylor MD. Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease. JACC Cardiovasc Imaging. 2016 Mar; 9(3):243-52.
-
Morris L, Desai A, Akkus NI. Anterolateral papillary muscle rupture after intervention of the right coronary artery. Rev Port Cardiol. 2015 Nov; 34(11):693.e1-3.
-
Birnkrant DJ, Ararat E, Mhanna MJ. Cardiac phenotype determines survival in Duchenne muscular dystrophy. Pediatr Pulmonol. 2016 Jan; 51(1):70-6.
-
Vallurupalli S, Pothineni NV, Deshmukh A, Paydak H. Utility of Routine Exercise Testing to Detect Rate-Related QRS Widening in Patients Without Structural Heart Disease on Class Ic Antiarrhythmic Agents (Flecainide and Propafenone). Am J Cardiol. 2015 Sep 01; 116(5):730-2.
-
Singh P, Sharma R, McElhanon K, Allen CD, Megyesi JK, Beneš H, Singh SP. Sulforaphane protects the heart from doxorubicin-induced toxicity. Free Radic Biol Med. 2015 Sep; 86:90-101.
-
Lang SM, Shugh S, Mazur W, Sticka JJ, Rattan MS, Jefferies JL, Taylor MD. Myocardial Fibrosis and Left Ventricular Dysfunction in Duchenne Muscular Dystrophy Carriers Using Cardiac Magnetic Resonance Imaging. Pediatr Cardiol. 2015 Oct; 36(7):1495-501.
-
Moore JP, Patel PA, Shannon KM, Albers EL, Salerno JC, Stein MA, Stephenson EA, Mohan S, Shah MJ, Asakai H, Pflaumer A, Czosek RJ, Everitt MD, Garnreiter JM, McCanta AC, Papez AL, Escudero C, Sanatani S, Cain NB, Kannankeril PJ, Bratincsak A, Mandapati R, Silva JN, Knecht KR, Balaji S. Predictors of myocardial recovery in pediatric tachycardia-induced cardiomyopathy. Heart Rhythm. 2014 Jul; 11(7):1163-9.
-
Liu YC, Reddi HV, Waheed S, Alapat D, Highsmith WE, Edmondson RD, Barlogie B, van Rhee F. A compound T60A and V122I heterozygosity in the transthyretin gene causing early onset severe cardiac amyloidosis. Amyloid. 2014 Jun; 21(2):134-5.
-
Reddi HV, Jenkins S, Theis J, Thomas BC, Connors LH, Van Rhee F, Highsmith WE. Homozygosity for the V122I mutation in transthyretin is associated with earlier onset of cardiac amyloidosis in the African American population in the seventh decade of life. J Mol Diagn. 2014 Jan; 16(1):68-74.
-
Deshmukh A, Sewani A, Sachdeva R. Cardiac sarcoidosis masquerading as syncope with right ventricular septal mass. J Invasive Cardiol. 2012 Aug; 24(8):418-9.
-
Lynch JM, Maillet M, Vanhoutte D, Schloemer A, Sargent MA, Blair NS, Lynch KA, Okada T, Aronow BJ, Osinska H, Prywes R, Lorenz JN, Mori K, Lawler J, Robbins J, Molkentin JD. A thrombospondin-dependent pathway for a protective ER stress response. Cell. 2012 Jun 08; 149(6):1257-68.
-
Pandey T, Jambhekar K, Shaikh R, Lensing S, Viswamitra S. Utility of the inversion scout sequence (TI scout) in diagnosing myocardial amyloid infiltration. Int J Cardiovasc Imaging. 2013 Jan; 29(1):103-12.
-
Bermudez CA, Rocha RV, Toyoda Y, Zaldonis D, Sappington PL, Mulukutla S, Marroquin OC, Toma C, Bhama JK, Kormos RL. Extracorporeal membrane oxygenation for advanced refractory shock in acute and chronic cardiomyopathy. Ann Thorac Surg. 2011 Dec; 92(6):2125-31.
-
McKernan NP, Culp WC, Knight WL, Johnston WE, Sniecinski RM, Lazar HL. CASE 2--2012 intraoperative diagnosis and management of caseous calcification of the mitral annulus. J Cardiothorac Vasc Anesth. 2012 Apr; 26(2):327-32.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|